Assess whether to bid as prime, sub, or no-bid after a debrief that

SITUATION In a lab competing a Phase II SBIR, SBIR Phase II commercialization appendix is the evidence after a debrief that contradicts the evaluation-notice scores. CMMC implementation lead has to pick To bid as prime, sub, or No-bid for this Government RFP Capture and Pricing close using SBIR Phase II commercialization appendix.

DECISION CMMC implementation lead in a lab competing a Phase II SBIR must choose To bid as prime, sub, / No-bid using SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores.

HYPOTHESES TO TEST 1. CMMC implementation lead can defend To bid as prime, sub, from SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores in a Government RFP challenge. 2. CMMC implementation lead cannot defend To bid as prime, sub, from SBIR Phase II commercialization appendix; No-bid is what the extract actually supports after a debrief that contradicts the evaluation-notice scores. 3. A debrief that contradicts the evaluation-notice scores never reached the population in SBIR Phase II commercialization appendix — reopen intake, do not close to bid as prime, sub, or no-bid. 4. Two facts in SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores conflict for CMMC implementation lead; hold this Capture and Pricing file.

ANALYSIS REQUIRED 1. Test OCI, QASP, and mandatory evaluation rights a lab competing a Phase II SBIR cannot waive quietly. 2. Map Section L/M requirements in SBIR Phase II commercialization appendix to evaluator notes after a debrief that contradicts the evaluation-notice scores. 3. Compare teaming and past-performance claims to what SBIR Phase II commercialization appendix attaches. 4. For this Government RFP Capture and Pricing file, read SBIR Phase II commercialization appendix against a debrief that contradicts the evaluation-notice scores and write the one fact that would move to bid as prime, sub, or no-bid for CMMC implementation lead.

RECOMMENDATION Choose To bid as prime, sub, / No-bid on this Government RFP / Capture and Pricing packet (SBIR Phase II commercialization appendix after a debrief that contradicts the evaluation-notice scores). Lead with the Government RFP option SBIR Phase II commercialization appendix can support after a debrief that contradicts the evaluation-notice scores, then the two facts that force it, then the Monday action for CMMC implementation lead in a lab competing a Phase II SBIR.

COMMAND RETURNS - Bottom-line Government RFP option on to bid as prime, sub, or no-bid, then the evidence in SBIR Phase II commercialization appendix, then the action for CMMC implementation lead - Hypothesis scorecard against SBIR Phase II commercialization appendix: supported / rejected / untestable - Regulatory or exam hook Capture and Pricing would cite - Capture and Pricing finding in SBIR Phase II commercialization appendix that a second reviewer can re-perform